Atrial Fibrillation (AF) trials recruiting in Ohio

All Atrial Fibrillation (AF) trials nationally

Cities in Ohio

Recruiting trials in Ohio

• Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study
  NCT06935591 · Phase: Not applicable (e.g. observational or device study) · Ages: 22 Years and older · Sex: All (male and female) · Ohio: Columbus, Toledo
• Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
  NCT06784466 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: All (male and female) · Ohio: Cincinnati, Cleveland, Columbus
• Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
  NCT07298473 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Cleveland, Columbus
• Novel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial Fibrillation
  NCT07436299 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Cleveland
• Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
  NCT07175428 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Marion, Maumee
• Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
  NCT07626411 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Marion
• Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
  NCT07430956 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Ohio: Marion
• Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
  NCT05712200 · Phase: Phase 3 · Ages: 65 Years and older · Sex: All (male and female) · Ohio: Beavercreek, Dayton